Evaluation of the Invest in Play Program - a New Parent Intervention for Children With Problem Behavior
NCT ID: NCT06984809
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
180 participants
INTERVENTIONAL
2025-09-25
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Does the iiP program reduce children's problem behaviors?
Researchers will compare families in the iiP program to families in a control group to see if the program leads to better outcomes for children and parents.
Participants will be randomly assigned to either the iiP program group or the control group and complete surveys before and after the program to see if iiP is reducing children's problem behaviors.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The control condition will receive usual care, e.g., further assessments, school meetings, individual care and/or psycho education.
No interventions assigned to this group
Invest in Play group
Intervention group receiving Invest in Play (iiP), a 12 session program provided weekly to parents with children with problem behavior.
Intervention
The intervention group will receive Invest in Play (iiP), a 12 session group-based parent program, which is led by two trained group leaders.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
The intervention group will receive Invest in Play (iiP), a 12 session group-based parent program, which is led by two trained group leaders.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children scoring above a pre-defined mean cut off score (over the 90 percentile) on the Eyberg Child Behavior Inventory (ECBI; Eyberg \& Ross, 1978) based on Norwegian norms (Reedtz et al., 2008), as reported by parents.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NORCE Norwegian Research Centre AS
OTHER
NTNU Health (sponsor)
UNKNOWN
University of Tromso
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lene-Mari P. Rasmussen, Ph.d
Role: PRINCIPAL_INVESTIGATOR
UiT The Arctic University of Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland university hospital, department of mental health care for children and adolescents
Bergen, , Norway
Helse Fonna HF, BUP Stord
Haugesund, , Norway
Helse Nord-Trøndelag HF, Barne- og ungdomspsykiatrisk avdeling (BUP)
Namsos, , Norway
OUS/PHA/BUPA/BUP Oslo Nord
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bjørn Brunborg
Role: primary
Ingvild Kaldråstøyl
Role: primary
Helge Børresen
Role: backup
Gaute Skribekk, lic.jur
Role: primary
Marianne Robertsen
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-957314
Identifier Type: OTHER
Identifier Source: secondary_id
2024/785387
Identifier Type: -
Identifier Source: org_study_id